Restrictive vs liberal red blood cell transfusion strategies in patients with acute myocardial infarction and anemia: Rationale and design of the REALITY trial

por Ducrocq, Gregory, Calvo, Gonzalo, González‐Juanatey, José Ramón, Durand‐Zaleski, Isabelle, Avendano‐Sola, Cristina, Puymirat, Etienne, Lemesle, Gilles, Arnaiz, Joan Albert, Martínez‐Sellés, Manuel, Rousseau, Alexandra, Cachanado, Marine, Vicaut, Eric, Silvain, Johanne, Karam, Carma, Danchin, Nicolas, Simon, Tabassome, Steg, Philippe Gabriel
Publicado 2021

Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum

por Bukata, Susan V., Blay, Jean-Yves, Rutkowski, Piotr, Skubitz, Keith, Henshaw, Robert, Seeger, Leanne, Dai, Tian, Jandial, Danielle, Chawla, Sant
Publicado 2021

The value of mammography in women with focal breast complaints in addition to initial targeted ultrasound

por Appelman, L., Appelman, P. T. M., Siebers, C. C. N., Bult, P., Go, H. L. S., Schlooz, M., Mann, R. M.
Publicado 2020

Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study

por Simons, Janine M., Jacobs, Julien G., Roijers, Joost P., Beek, Maarten A., Boonman-de Winter, Leandra J. M., Rijken, Arjen M., Gobardhan, Paul D., Wijsman, Jan H., Tetteroo, Eric, Heijns, Joan B., Yick, C. Y., Luiten, Ernest J. T.
Publicado 2020

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

por Capell, Warren H., Barnathan, Elliot S., Piazza, Gregory, Spyropoulos, Alex C., Hsia, Judith, Bull, Scott, Lipardi, Concetta, Sugarmann, Chiara, Suh, Eunyoung, Rao, Jaya Prakash, Hiatt, William R., Bonaca, Marc P.
Publicado 2021

Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial

por Lugtenberg, Rieneke T., de Groot, Stefanie, Kaptein, Ad A., Fischer, Maarten J., Kranenbarg, Elma Meershoek-Klein, Carpentier, Marjolijn Duijm-de, Cohen, Danielle, de Graaf, Hiltje, Heijns, Joan B., Portielje, Johanneke E. A., van de Wouw, Agnes J., Imholz, Alex L. T., Kessels, Lonneke W., Vrijaldenhoven, Suzan, Baars, Arnold, Fiocco, Marta, van der Hoeven, Jacobus J. M., Gelderblom, Hans, Longo, Valter D., Pijl, Hanno, Kroep, Judith R.
Publicado 2020

Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial

por Raphael Daniela, D. B., Russell, N. S., van Werkhoven, E., Immink, J. M., Westhoff, D. P. G., Stenfert Kroese, M. C., Stam, M. R., van Maurik, L. M., van Gestel, C. M. J., van der Weijden, T., Boersma, L. J.
Publicado 2020

To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?

por Herbert, S. L., Wöckel, A., Kreienberg, R., Kühn, T., Flock, F., Felberbaum, R., Janni, W., Curtaz, C., Kiesel, M., Stüber, T., Diessner, J., Salmen, J., Schwentner, L., Fink, V., Bekes, I., Leinert, E., Lato, K., Polasik, A., Schochter, F., Singer, S.
Publicado 2020

The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measureme...

por Shah, Chirag, Zambelli-Weiner, April, Delgado, Nicole, Sier, Ashley, Bauserman, Robert, Nelms, Jerrod
Publicado 2020

Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase

por Sachdev, Jasgit C., Munster, Pamela, Northfelt, Donald W., Han, Hyo Sook, Ma, Cynthia, Maxwell, Fiona, Wang, Tiffany, Belanger, Bruce, Zhang, Bin, Moore, Yan, Thiagalingam, Arunthathi, Anders, Carey
Publicado 2020

Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects

por Boettcher, Michael, Thomas, Dirk, Mueck, Wolfgang, Loewen, Stephanie, Arens, Erich, Yoshikawa, Kenichi, Becker, Corina
Publicado 2020

Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer

por Richman, Juliet, Ring, Alistair, Dowsett, Mitch, Sestak, Ivana
Publicado 2020

Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur–uracil with CMF (N·SAS-BC 01 trial and CUBC trial)

por Ohno, Shinji, Saji, Shigehira, Masuda, Norikazu, Tsuda, Hitoshi, Akiyama, Futoshi, Kurosumi, Masafumi, Shimomura, Akihiko, Sato, Nobuaki, Takao, Shintaro, Ohsumi, Shozo, Tokuda, Yutaka, Inaji, Hideo, Watanabe, Toru, Ohashi, Yasuo
Publicado 2020

The EXCEL Trial: The Interventionalists' Perspective

por Hunter, George William, Sharma, Vinoda, Varma, Chetan, Connolly, Derek
Publicado 2021

Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial

por Yap, Jonathan, Chew, Derek P, Stone, Gregg W, Tan, Jack Wei Chieh
Publicado 2021

Sphincter preservation in patients with low rectal cancer: striking the right oncological balance

por Luvisetto, Federico, Shamali, Awad, Rutgers, Marieke L. W., Flashman, Karen, Khan, Jim S.
Publicado 2021

Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey

por McGee, Sharon, Alzahrani, Mashari, Vandermeer, Lisa, Cole, Katherine, Larocque, Gail, Awan, Arif, Hutton, Brian, Pond, Gregory, Saunders, Deanna, Clemons, Mark
Publicado 2021

Interim Analysis of a Phase 2 Open‐Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor‐Induced Osteomalacia

por Imanishi, Yasuo, Ito, Nobuaki, Rhee, Yumie, Takeuchi, Yasuhiro, Shin, Chan Soo, Takahashi, Yutaka, Onuma, Hiroki, Kojima, Masahiro, Kanematsu, Masanori, Kanda, Hironori, Seino, Yoshiki, Fukumoto, Seiji
Publicado 2020

Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials

por Goetz, Matthew P., Okera, Meena, Wildiers, Hans, Campone, Mario, Grischke, Eva-Maria, Manso, Luis, André, Valérie A. M., Chouaki, Nadia, San Antonio, Belén, Toi, Masakazu, Sledge, George W.
Publicado 2021

CTCs-oriented adjuvant personalized cytostatic therapy non-metastatic breast cancer patients: continuous non-randomized prospective study and prospective randomized controlled stud...

por Shliakhtunou, Ya A.
Publicado 2021